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Diabetic patients exhibit a reduction in β cells, which secrete insulin to help regulate glucose homeostasis; 
however, little is known about the factors that regulate proliferation of these cells in human pancreas. Access 
to primary human β cells is limited and a challenge for both functional studies and drug discovery progress. 
We previously reported the generation of a human β cell line (EndoC-βH1) that was generated from human 
fetal pancreas by targeted oncogenesis followed by in vivo cell differentiation in mice. EndoC-βH1 cells dis-
play many functional properties of adult β cells, including expression of β cell markers and insulin secretion 
following glucose stimulation; however, unlike primary β cells, EndoC-βH1 cells continuously proliferate. 
Here, we devised a strategy to generate conditionally immortalized human β cell lines based on Cre-mediated 
excision of the immortalizing transgenes. The resulting cell line (EndoC-βH2) could be massively amplified 
in vitro. After expansion, transgenes were efficiently excised upon Cre expression, leading to an arrest of cell 
proliferation and pronounced enhancement of β cell–specific features such as insulin expression, content, 
and secretion. Our data indicate that excised EndoC-βH2 cells are highly representative of human β cells and 
should be a valuable tool for further analysis of human β cells.
Introduction
Insulin-producing pancreatic β cells play a central role in glyce-
mic regulation. Such β cells are destroyed in patients with type 1 
diabetes, while in type 2 diabetes patients, functional β cell mass 
decreases and to a certain point fails to produce enough insulin to 
insure adequate blood glucose control. In this context, dissecting 
the mechanisms that control the size of the human β cell pool 
represents a major challenge.
During the past years, significant progress appeared on mech-
anisms that regulate β cell mass in the adult pancreas. In adult 
mice, while β cells develop from rare adult pancreatic progenitors 
following partial pancreatic duct ligation, it is now accepted that 
during adulthood under normal or regenerative conditions, the 
majority of the newly formed β cells are generated by β cell dupli-
cation (1). The demonstration of the importance of rodent β cell 
proliferation as the main regulator of β cell mass (2) was paralleled 
by a large amount of data that dissected signals and pathways that 
control rodent β cell proliferation (3). In this context, betatrophin 
was recently characterized as a new hormone that efficiently con-
trols mouse β cell proliferation (4). Thus, β cell proliferation rep-
resents an important parameter in β cell mass regulation in mice.
In humans, little is known about control of β cell mass in the 
adult pancreas. However, human β cell proliferation is rare in the 
adult pancreas (5) and human β cell turnover is extremely low, as 
determined by in vivo thymidine analog incorporation, radiocar-
bon dating, and mathematical modeling of lipofuscin accumula-
tion (6, 7). Moreover, when compared with what occurs in mice, 
very few signals are described as activating human β cell prolif-
eration (8). Finally, human β cells seem refractory to forced cell 
expansion, and this point remains unexplained (9). This lack 
of knowledge is at least in part due to limited access to purified 
human β cells in sufficient quantities.
Recently, by targeted oncogenesis, we generated a human pan-
creatic β cell line, EndoC-βH1 (10, 11). Human fetal pancreases 
were transduced with lentiviral vectors expressing the large T 
antigen of simian virus 40 (SV40 LT) and human telomerase 
reverse transcriptase (hTERT) and were transplanted into SCID 
mice to allow pancreatic differentiation (11). Importantly, the 
immortalizing transgenes were under the control of the rat insu-
lin 2 promoter. Thus, the human β cells that developed in SCID 
mice during tissue differentiation expressed the transgenes lead-
ing to the development of insulinomas that were further ampli-
fied in culture to generate cell lines such as EndoC-βH1 (10). 
EndoC-βH1 cells expressed insulin and numerous β cell–specific 
markers and secreted insulin upon glucose and secretagogue 
stimulation. Collectively, the phenotype and function of EndoC-
βH1 cells are close to that of primary adult human β cells with 
one major difference. Indeed, as described above, human adult 
β cells proliferate extremely poorly, while EndoC-βH1 cells are 
continuously expanding.
Here, we generated a human β cell line, EndoC-βH2, by targeted 
oncogenesis with lentiviral vectors expressing excisable SV40 LT 
and hTERT. Following excision of immortalizing transgenes, cell 
proliferation sharply decreased, which was paralleled by a massive 
enhancement of β cell–specific features such as increased insulin 
gene expression and content. Such a cell line represents a major step 
forward toward the development of authentic human β cells. It also 
represents a unique tool for studying human β cell proliferation.
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Figure 1
Strategy to produce reversely immortalized cell line and immunofluorescence analysis of EndoC-βH2 cells. (A) Schematic representation of 
excisable lentiviral vector used to produce the EndoC-βH2 reversely immortalized cell line. (B) Immunofluorescence analysis of EndoC-βH2 
cells. EndoC-βH2 cells stained positive for insulin (INS) and coexpressed C-peptide (C-PEPT), CHGA, PDX1, NKX6.1, SV40 LT, and Ki67. The 
cells rarely express somatostatin (SST) and do not express glucagon (GCG), amylase (AMY), carboxipeptidase-A (CPA), or SOX9. Nuclei were 
stained with Hoechst 33342 fluorescent stain (blue). Photographs of all insulin stainings were taken using a 700 ms acquisition time to obtain 
an unsaturated signal. Scale bars: 50 μm.
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mogranin-A (CHGA), as was the case for human adult pancreatic 
β cells. The insulinoma stained negative for glucagon, a marker of 
α cells, and for carboxypeptidase-A (CPA), a marker of acinar cells 
(Supplemental Figure 1B). Finally, very rare cells in the insulinoma 
coexpressed insulin and somatostatin (Supplemental Figure 1B).
The remaining part of the insulinoma was dissociated and used to 
derive a human β cell line, EndoC-βH2 (Supplemental Figure 1C), 
using previously described culture conditions (10). PCR performed 
on genomic DNA indicated that EndoC-βH2 cells have integrated 
both SV40 LT and hTERT transgenes (Supplemental Figure 1D). 
EndoC-βH2 cells proliferated with a doubling time of 5 to 7 days. 
Immunocytochemistry indicated that EndoC-βH2 cells were posi-
tive for insulin, C-peptide, CHGA, PDX1, and NKX6-1 (Figure 1B). 
Cells were positive for SV40 LT and were proliferating as indicated 
by Ki67 staining (Figure 1B). Cells stained negative for glucagon, 
and only rare cells were observed that expressed somatostatin (Fig-
ure 1B). EndoC-βH2 cells stained negative for CPA and amylase, 2 
acinar markers, and for SOX9, a ductal marker (Figure 1B).
Cre-mediated excision of immortalizing transgenes sharply decreases 
EndoC-βH2 cell proliferation. We transduced EndoC-βH2 cells with 
increasing amounts of lentiviral vector (from 15 ng to 60 ng of p24 
capside protein per 105 cells) expressing Cre under the control of a 
CMV ubiquitous promoter to titrate the amount of Cre-expressing 
lentiviral vector that yielded optimal transduction efficacy with a 
minimal amount of lentiviral vector (Supplemental Figure 2A). We 
used the appropriate lentiviral titer (15 ng of p24 capsid protein 
per 105 cells) to transduce EndoC-βH2 cells with a Cre-expressing 
lentiviral vector. As a control, 60 ng of p24 capside protein (highest 
Results
Generation of a human β cell line with excisable immortalizing transgenes. 
We previously developed a human β cell line, EndoC-βH1, by tar-
geted oncogenesis mediated by lentiviral integration of 2 immor-
talizing transgenes, SV40 LT and hTERT, in human fetal pancreas 
(10). Here, we aimed at generating conditionally immortalized 
β cell lines in which immortalizing transgenes could be excised. For 
this purpose, lentiviral vectors were modified through the insertion 
of a loxP site within the U3 truncated region (Delta U3) of the 3′ 
LTR. In such a configuration, after integration in the genome of 
transduced cells, the Delta U3 loxP region is duplicated and 2 loxP 
sites flank the integrated sequences, allowing subsequent excision 
dependent on Cre recombinase expression (Figure 1A).
Excisable lentiviral vectors were constructed to express SV40 
LT or hTERT under the control of a 405-nt fragment of the rat 
insulin-2 promoter. A 9-week-old human fetal pancreas was 
simultaneously transduced with both lentiviral vectors and trans-
planted under the kidney capsule of a recipient SCID mouse. At 
6.5 months later, an insulinoma had developed from the trans-
planted tissue. The insulinoma was removed, dissociated, and fur-
ther amplified in vivo by 3 successive rounds of transplantation 
(Supplemental Figure 1A; supplemental material available online 
with this article; doi:10.1172/JCI72674DS1). Part of the final insu-
linoma was analyzed by immunohistochemistry. Insulinoma cells 
stained positive for insulin and SV40 LT (Supplemental Figure 
1B). They also stained positive for Ki67, which was not the case 
for human adult pancreatic β cells. The insulinoma cells stained 
positive for PDX1 and expressed the pan-endocrine marker chro-
Figure 2
Excision of immortalizing transgenes blocks proliferation. EndoC-βH2 cells were transduced with either Cre- or GFP-expressing lentiviral vectors 
and analyzed 21 days later. (A) SV40 LT and hTERT expression were analyzed by RT-QPCR. Results are presented normalized to cyclophilin 
and relative to control nontransduced EndoC-βH2 cells. Results are shown as mean ± SD of 3 independent RNA preparations. The experiment 
was replicated 2 times. (B) Immunofluorescence analysis of SV40 LT (green) and insulin (red) in nonexcised cells (–CRE) and excised EndoC-
βH2 cells (+CRE). Nuclei were stained with Hoechst 33342 fluorescent stain (blue). The settings of confocal images were used to obtain an 
unsaturated insulin signal for excised EndoC-βH2 cells. The same settings were used to generate the insulin image for nonexcised EndoC-βH2 
cells. Scale bars: 50 μm. (C) Ki67 expression was analyzed by RT-QPCR. Results are presented normalized to cyclophilin and relative to control 
nontransduced EndoC-βH2 cells. Results are shown as mean ± SD of 3 independent RNA preparations. (D). BrdU incorporation by nonexcised 
and excised EndoC-βH2 cells following a 1-hour BrdU pulse. Results are presented as a mean percentage ± SD.
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sion of the cyclin-dependent kinase inhibitor 1A (CDKN1A) that 
is negatively linked to cell cycle strongly increased following 
transgene deletion (Figure 3). Interestingly, in the nonexcised ver-
sus islet comparison, the same ingenuity categories were retrieved 
and displayed similarly highly significant P values (Table 1). 
This demonstrates that nonexcised cells are as distant from 
islets as they are from excised cells with respect to cell-cycle func-
tions. More importantly, when excised cells were compared with 
islets, the previously observed differences failed to be significant 
(P > 0.05) for 11 out of 16 ingenuity function annotations. 
Although 5 ingenuity function annotations were still signifi-
cantly different, their corresponding P values were always much 
less significant (i.e., interphase P values varied from 10–14 to 10–6) 
(Table 1). Finally, comparative analyses of cell-cycle–related genes 
performed by quantitative PCR (QPCR) and Western blot further 
demonstrated that the expression of CDK1, CCNE2, and CCNB2 
decreased following excision to reach levels that resemble those 
found in islets (Supplemental Figure 3 and Supplemental Figure 4). 
Interestingly, CCND1 was found absent in EndoC-βH2 but 
expressed in islet cell preparations (Supplemental Figure 4).
Gene expression pattern in EndoC-βH2. Comparative transcriptom-
ic analysis was next performed to determine the expression profile 
of EndoC-βH2 before and after transgene excision in comparison 
with human islet preparation and the human duct cell line SKPC 
(12). It revealed that nonexcised EndoC-βH2 cells were highly 
enriched in the expression of a large number of β cell–specific 
genes (Figure 4A). Similar comparisons indicated very low levels 
of expression of exocrine genes in nonexcised EndoC-βH2 cells 
(Figure 4B). Moreover, the expression of exocrine markers did not 
increase following excision, while the expression of β cell markers 
did not decrease following excision (Figure 4). In fact, as described 
below, the expression of a set of β cell–specific markers increased 
following excision. Collectively, both before and after transgene 
titer tested) of a GFP-expressing lentiviral vector was used. Cells 
were analyzed 21 days following transduction. At the RNA level, 
upon Cre transduction, SV40 LT levels decreased by 92% and exog-
enous hTERT expression was reduced by 96% (Figure 2A). Such a 
sharp decrease in SV40 LT levels was also observed by immunocy-
tochemistry (Figure 2B). Moreover, upon Cre transduction, Ki67 
mRNA levels decreased by 97%, an effect that was not observed 
when cells were transduced with a GFP-expressing lentiviral vector 
(Figure 2C). This major decrease in Ki67 expression was paralleled 
by a decrease in BrdU incorporation in Cre-expressing cells. Spe-
cifically, over a 1-hour pulse period, 14% of nontransduced cells 
incorporated BrdU whereas 0.9% of Cre-transduced cells incorpo-
rated BrdU (Figure 2D). Of note, EndoC-βH2 efficiently survived 
the virus-mediated excision procedure. Specifically, with 15 ng per 
105 cells of Cre-expressing vector, cell number was decreased by 
7% at day 7. This level of decrease was similar to that found when 
cells were transduced with a GFP-expressing vector. By days 14 and 
21, as expected, β cell number increased in cells transduced with a 
GFP-expressing vector at 60 ng of p24 capside protein (the highest 
concentration tested), while cell number decreased very slowly in 
cells transduced with 15 ng of p24 capside protein per 105 cells of 
Cre-expressing vector (15.8% decrease at day 14 and 21% decrease 
at day 21) (Supplemental Figure 2B).
Ingenuity pathway analysis indicated significant differences 
between nonexcised and excised cells for 16 ingenuity function 
annotations linked to cell cycle with highly significant P values 
(between 2.66 × 10–20 and 1.54 × 10–3) (Table 1). Specifically, the 
expression of many genes positively linked to cell proliferation 
decreased upon transgenes deletion. This is for example the case 
for cell division cycle family members (CDCs), kinesin family 
members (KIF), cyclin-dependent kinases such as CDK1, cyclins 
(CCN), E2F transcription factors, and additional cell-cycle–related 
genes such as MKI67 and FOXM1 (Figure 3). Similarly, the expres-
Table 1
Ingenuity pathway analysis
 EndoC-βH2 excised vs. nonexcised EndoC-βH2 nonexcised  EndoC-βH2 excised  
  vs. islets vs. islets
Function annotation Gene number Activation z-score P value P value P value
S phase 74 –4.682 3.03 × 10–11 1.40 × 10–11 3.63 × 10–04
Entry into interphase 40 –4.265 6.81 × 10–07 2.31 × 10–06 NS
Entry into S phase 33 –4.008 5.53 × 10–05 5.37 × 10–05 NS
interphase 157 –3.960 1.22 × 10–14 1.18 × 10–14 1.24 × 10–06
S phase of tumor cell lines 28 –3.507 1.16 × 10–05 1.80 × 10–08 3.98 × 10–03
Cytokinesis 38 –3.317 2.10 × 10–06 9.26 × 10–07 NS
Cycling of centrosome 18 –3.227 5.54 × 10–05 1.59 × 10–03 NS
M phase 68 –3.053 1.30 × 10–14 8.07 × 10–12 NS
Checkpoint control 50 –2.722 2.66 × 10–20 8.45 × 10–08 NS
M phase of tumor cell lines 32 –2.720 7.31 × 10–10 3.22 × 10–10 NS
Cytokinesis of tumor cell lines 19 –2.577 1.10 × 10–05 2.41 × 10–06 NS
Interphase of tumor cell lines 75 –2.487 5.82 × 10–07 6.00 × 10–09 6.49 × 10–05
Entry into S phase of fibroblasts 8 –2.430 1.54 × 10–03 5.34 × 10–04 NS
Mitosis of fibroblast cell lines 12 –2.423 1.11 × 10–06 2.18 × 10–05 NS
S phase of connective tissue cells 15 –2.177 3.67 × 10–05 4.96 × 10–06 NS
S phase of fibroblasts 14 –2.034 8.59 × 10–05 1.13 × 10–05 2.60 × 10–03
Ingenuity pathway analysis was performed using 3 different comparisons: EndoC-βH2 excised versus nonexcised cells; EndoC-βH2 nonexcised cells versus 
islets; and EndoC-βH2 excised cells versus islets. Regulated genes are mapped to functions with literature statements describing the effect of the gene in rela-
tion to the function. A statistical approach (z-score) determines whether a function has significantly more increased (z > 2) or decreased (z < –2) predictions. 
The top decreased biological functions involved in cell cycles are listed. P values indicate significant differences in the 3 comparisons. NS indicates P > 0.05.
Downloaded from http://www.jci.org on June  9, 2016.   http://dx.doi.org/10.1172/JCI72674
technical advance
 The Journal of Clinical Investigation   http://www.jci.org   Volume 124   Number 5   May 2014 2091
Figure 3
Excision of immortalizing transgenes 
modulates the expression of cell-
cycle–related genes. Heat map com-
parisons of the expression of a set of 
cell-cycle–related genes in EndoC-
βH2 nonexcised cells and excised 
cells versus human islets. The heat 
map shows the log intensities in 3 
sample sets of EndoC-βH2 nonex-
cised or excised cells and human 
islets (42). For genes represented by 
several probe sets, the probe set with 
the highest fold change was used. 
Gene list is ordered from low to high 
expression relative to human islet 
sample. Gene lists have been gener-
ated using published transcriptomic 
data (43), literature data, and manual 
curation.
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excision enhanced the intensity of insulin immunostaining when 
compared with nonexcised cells (Figure 5B). Interestingly, the rare 
cells that remained Ki67 positive were the ones that were low in 
terms of insulin immunostaining (Figure 5C). Insulin content 
increased by almost 20-fold 21 days after Cre transduction from an 
initial content of 62 ± 2.3 ng per million cells to 1.98 ± 0.048 μg per 
million cells (Figure 5D). Moreover, RT-QPCR analyses indicated 
that the expression of a number of genes linked to β cell function 
increased following Cre-mediated transgene deletion. This was 
the case for IAPP, SLC2A2, KCNJ11, ABCC8, and RAB3A (Figure 
5E). This was also the case for a number of transcription factors 
such as MAFA, GLIS3, NKX2-2, NKX6-1, PDX1, MNX1, and MYT1 
deletion, the gene expression pattern observed in EndoC-βH2 cells 
is consistent with human β cells.
EndoC-βH2 cell function following transgene excision. Twenty-one 
days following transduction of EndoC-βH2 cells with a Cre-
expressing lentiviral vector, we observed a sharp increase in insu-
lin mRNA levels (Figure 5A). Such an increase in insulin mRNA 
levels was not observed when cells were transduced with a GFP-
expressing lentiviral vector (Figure 5A). When compared with the 
previously published EndoC-βH1 line, nonexcised EndoC-βH2 
cells expressed 4.1-fold less insulin mRNA. However, upon exci-
sion, EndoC-βH2 cells expressed 2.9-fold more insulin mRNA 
than EndoC-βH1 (Figure 5A). At the protein level, Cre-mediated 
Figure 4
Heat map visualization of gene expression profiling in excised and unexcised EndoC-βH2 compared with human islets and exocrine cell line. 
(A) Expression of genes relevant for β cell function in heat map visualization. The heat map shows the log intensities in 3 sample sets of EndoC-
βH2 nonexcised or excised cells, human islets (42), and pancreas exocrine cell line SKPC. For genes represented by several probe sets, the 
probe set with the highest fold change was used. Most genes are highly expressed in the human β cell line EndoC-βH2 and in islet samples, but 
not in exocrine cell line SKPC. (B) Expression of exocrine marker genes in heat map visualization. The heat map shows the log intensities in 3 
sample sets of EndoC-βH2 nonexcised or excised cells, human islets (42), and pancreas exocrine cell line SKPC. Gene lists have been generated 
using published transcriptomics data (43), literature data, and manual curation. For genes represented by several probe sets, the probe set with 
the highest fold change was used. Most genes are not expressed in human β cell line EndoC-βH2 samples (excised or not), but in islet samples.
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and excised cells using the exact same number of seeded cells per 
well in the assay. Interestingly, at all glucose concentrations tested, 
the absolute values of secreted insulin per hour were much higher 
in excised cells compared with control nonexcised cells (Figure 
7A). Nonexcised cells failed to respond to glucose stimulation in 
the absence of IBMX, a phosphodiesterase inhibitor that increases 
intracellular levels of cAMP, but responded to glucose in the pres-
ence of IBMX. In the presence of IBMX, the stimulation index of 
nonexcised cells, defined as the ratio of secreted insulin at 15 mM 
glucose compared with 0.5 mM glucose, was 2.0 (Figure 7B). In 
excised cells, glucose induced insulin secretion both in the absence 
and in the presence of IBMX, with stimulation indexes of 3.8 and 
3.02, respectively (Figure 7C).
(Figure 6). Interestingly, when compared with islets, the expression 
of both MAFA and GLIS3 was particularly low in nonexcised cells, 
while the other transcription factors were expressed at similar level 
as in islets. Following transgene excision in EndoC-βH2 cells, we 
observed an 8-fold increase of MAFA expression (same magnitude 
as insulin induction) and a 2.5-fold increase in GLIS3 expression 
(Figure 6). Taken together, such data suggest that the increased 
expression of MAFA and GLIS3 that is particularly low in nonex-
cised cells could explain the important increase in insulin mRNA 
level that takes place following Cre-mediated excision.
Finally, we asked whether EndoC-βH2 cells remained glucose 
responsive following Cre-mediated transgene deletion. Static glu-
cose-stimulated insulin secretion was performed in both control 
Figure 5
Enhanced β cell–specific gene expression following excision. EndoC-βH2 cells were transduced with either Cre- or GFP-expressing lentiviral 
vectors and analyzed 21 days later. (A) Insulin expression was analyzed by RT-QPCR and compared with its expression in EndoC-βH1 and 
SKPC cells. Results are presented normalized to cyclophilin and relative to control nontransduced EndoC-βH2 cells. Results are mean ± SD 
of 3 independent RNA preparations. (B) Immunofluorescence analysis of insulin (red) in nonexcised cells (–CRE) and excised EndoC-βH2 
cells (+CRE). Nuclei were stained with Hoechst 33342 fluorescent stain (blue). Scale bars: 100 μm. (C) Immunofluorescence analysis of insulin 
(red) and Ki67 (green) in nonexcised cells (–CRE) and excised EndoC-βH2 cells (+CRE). Nuclei were stained with Hoechst 33342 fluorescent 
stain (blue). Scale bars: 50 μm (left and middle panel); 25 μm (right panel). In B and C, specific settings were applied in order to obtain confocal 
images with un-saturated insulin signal for excised EndoC-βH2 cells. The same settings were used to generate the insulin images for nonex-
cised EndoC-βH2 cells. (D) Insulin content in nonexcised and excised EndoC-βH2 cells. Results are shown as mean ± SEM of 3 independent 
cultures. The experiment was replicated 2 times. (E) IAPP, SLC2A2, ABCC8, KCNJ11, and RAB3A expression was analyzed by RT-QPCR. 
Results are presented normalized to cyclophilin and relative to control nontransduced EndoC-βH2 cells. Results are shown as mean ± SD of 
3 independent RNA preparations.
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at passage 59) (Supplemental Table 
1). In addition, in the presence of 
IBMX, glucose responsiveness was 
observed at all passages tested and 
fold induction of insulin secre-
tion between 2.8 mM and 15 mM 
glucose ranged between 2.35 (pas-
sage 77) and 3.8 (passage 62) (Sup-
plemental Table 1).
Finally, independently of passage 
number, transduction with Cre-
expressing lentiviral vector always 
resulted in growth arrest. BrdU 
incorporation tested at passages 62, 
105, and 120 was high before exci-
sion (between 14% and 16% of posi-
tive cells) and drastically decreased 
21 days following excision (between 
0.47% and 0.9% of positive cells). 
Furthermore, over the same pas-
sages, Ki67 mRNA expression mea-
sured by QPCR decreased follow-
ing excision by 97%, 96%, and 98% 
respectively.
Discussion
During the past 30 years, many 
studies aimed at generating func-
tional human pancreatic β cell 
lines showed an extremely low suc-
cess rate (13, 14). Interestingly, in 
2011, we and another independent 
laboratory generated human pan-
creatic β cell lines. The β cell lines 
developed by the Flatt’s laboratory 
were generated by electrofusion of 
freshly isolated human pancreatic 
β cells and the immortal human PANC-1 epithelial cell line (15). 
They contained limited amounts of insulin, but insulin secretion 
was dependent on glucose levels. We developed human β cell lines 
using an approach based on targeted oncogenesis by transduc-
ing human fetal pancreases with lentiviral vectors that expressed 
SV40 LT and hTERT under the control of the insulin promoter. 
One cell line, EndoC-βH1, developed with this approach expressed 
fair amounts of insulin, and insulin secretion was regulated by 
glucose (10). EndoC-βH1 cells shared many similarities with pri-
mary human β cells. However, as a cell line, EndoC-βH1 cells are 
in essence proliferating cells, while primary human adult β cells 
proliferate extremely poorly. In order to move closer to a genuine 
human β cell, we developed in the present work a conditionally 
immortalized human pancreatic β cell line.
As a first step, we developed new insulinomas using excisable 
lentiviral vectors, from which we derived a new human β cell line, 
EndoC-βH2, which was analyzed in detail. Currently, studies on 
human β cell biology are dependent on access to preparations of 
human islets derived from cadaveric donors. In addition to lim-
ited access to human islet preparations and to major variability 
from one donor to the other, β cells only represent a subfraction 
of cells present in islet preparations that contain other endocrine 
cell types, but also exocrine cells (16, 17). This lack of β cell purity 
Collectively, our data demonstrate that upon Cre expression, SV40 
LT and hTERT can be efficiently excised in the EndoC-βH2 cell line, 
leading to proliferation arrest and enhancement of β cell function.
EndoC-βH2 cell stability. We analyzed the stability of EndoC-βH2 
at different passages on 3 important features: (a) chromosomal 
stability; (b) insulin content and secretion; and (c) proliferation 
arrest upon excision of immortalizing transgenes.
Comparative genomic hybridization (CGH array) profiles indi-
cated that, as expected for SV40LT-transformed cells, the chromo-
somal structure of the cells was abnormal (Supplemental Figure 5). 
But most importantly, when CGH array analysis was performed at 
2 different passages, namely p34 and p85, the exact same profile 
was observed, indicating that although chromosomal structure 
was abnormal, the structure is very stable over time (Supplemen-
tal Figure 5). Indeed, within a complete year in culture from p34 
to p85, no changes were observed, suggesting that continuous 
SV40LT expression by EndoC-βH2 does not induce cumulative 
chromosomal modifications.
Insulin content was measured at passages 46, 59, 62, and 77. It 
was stable before excision (minimal value 0.062 μg/million cells at 
passage 62; maximal value 0.090 μg/million cells at passage 59) and 
systematically increased following excision (minimal value 1.98 
μg/million cells at passage 62; maximal value 2.75 μg/million cells 
Figure 6
Expression of β cell transcription factors before and after excision. RT-QPCR was performed to com-
pare the level of expression of a set of β cell transcription factors (MAFA, GLIS3, RFX6, NKX2-2, 
NKX6-1, PDX1, MYT1, MNX1, and PAX6) among EndoC-βH2 nonexcised control cells, Cre-trans-
duced excised EndoC-βH2 cells, GFP-transduced EndoC-βH2 cells, and islets. QPCR was normalized 
relative to TBP expression, and the relative expression of each transcription factor was arbitrary set to 
1 for the control nonexcised EndoC-βH2 cells. Three independent RNA extractions were performed for 
each culture condition (control, Cre, and GFP) and 1 for the human islet preparation. QPCR was per-
formed in quadruplicate. Results are shown as mean ± SEM. *P < 0.0002, unpaired 2-tailed Student’s 
t test with Welch correction.
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excision via the Cre recombinase (20–22). Similar approaches 
were used to produce reversely immortalized human liver sinu-
soidal endothelial cells and β cells (23, 24) and primate hepatic 
progenitor cell lines (25). However, the first β cell line developed 
with this approach rapidly lost insulin expression (23). The sec-
ond line, NAKT-15, reported in 2005 (24), was not further studied 
or distributed despite its promising β cell–specific properties. In 
addition, upon Cre-mediated SV40 LT deletion in primate hepatic 
progenitor cell lines, cells exhibited picnotic or fragmented nuclei 
characteristics of apoptosis and died, which was suggested to be 
due to p53 accumulation (25). Here, we used excisable lentiviral 
vectors to generate a stable conditionally immortalized functional 
human β cell line. We found that immortalizing transgenes can be 
efficiently deleted in more than 90% of EndoC-βH2 cells, giving 
rise to cellular growth arrest. This demonstrated that proliferation 
was dependent upon transgene expression. In our present work, 
cell death following Cre expression was a minor phenomenon and 
cells survived efficiently for at least 3 weeks following excision. In 
fact, we performed the majority of the experiments 3 weeks fol-
lowing Cre transduction, and not only did excised cells survive, 
but the expression of a number of markers of differentiated β cells 
increased. This was the case for insulin and the islet amyloid poly-
peptide (IAPP), which is coexpressed and cosecreted with insulin 
by primary β cells (26). This is also the case for the glucose trans-
porter SLC2A2, for ABCC8 and KCNJ11 and for RAB3A, which are 
all implicated in glucose-stimulated insulin secretion (27). Our 
data thus indicate that by deleting immortalizing transgenes and 
blocking cell proliferation, we increased the β cell differentiation 
status. β Cells are highly differentiated cells with more than 30% 
of mRNA that encodes insulin (28). Developing and maintain-
ing such a differentiated status is an active process that requires 
energy (29). Energy is also necessary for cell proliferation. We thus 
hypothesize that the observed increase of β cell differentiation sta-
tus following cell growth arrest reflects the classical but not yet 
fully explained balance between the processes of cell proliferation 
and differentiation. The above-described model will be useful in 
dissecting how this balance is regulated.
In 2004, Dor and colleagues demonstrated the major role of 
β cell proliferation in β cell mass regulation in adult mice (2), and 
this seminal work was followed by a series of studies that analyzed 
β cell proliferation in humans. Since then, while major progress 
appeared on rodent β cell proliferation, information on human 
β cell proliferation remained extremely scarce (8). This is at least 
in part due to the difficult access to primary human islets. This 
is also due to the fact that β cells represent only a sub-fraction of 
such human islet cell preparations, which complicates the use of 
human islet preparations in large-scale screenings. Here, we dem-
onstrate that excised EndoC-βH2 cells express very low levels of 
CDK1, CCNE2, and CCNB2, as is the case for human islets, while 
in such preparations represents a limitation in the interpretation 
of data derived from transcriptomic analysis. Here, comparative 
transcriptional analyses indicated that EndoC-βH2 cells expressed 
the set of β cell–specific genes also found in human islet cell prepa-
rations. Moreover, while the expression of many exocrine mark-
ers was detected in human islet cell preparations, this was not the 
case in EndoC-βH2 cells. Such a new cell line will thus be useful 
for experiments where large numbers of pure insulin-producing 
human pancreatic β cells are needed.
In the past, a number of approaches were used to produce con-
ditionally immortalized cell lines. A thermosensitive variant of 
SV40 LT and approaches based on tetracyclin-mediated regula-
tion of SV40 LT expression have been used to respectively develop 
mouse striatal progenitor cell lines (18) and mouse β cell lines (19). 
Control of immortalizing transgene expression was also achieved 
in a more permanent way. Conditionally immortalized cell lines 
were produced following retroviral-mediated stable integration 
of immortalizing transgenes flanked by loxP sites, allowing their 
Figure 7
Insulin secretion by EndoC-βH2 cells following Cre-mediated exci-
sion. EndoC-βH2 cells were transduced with Cre-expressing lentiviral 
vectors and analyzed 21 days later. Control nonexcised and excised 
EndoC-βH2 cells were tested for static insulin secretion under vari-
ous glucose concentrations in the presence or absence of IBMX. In A, 
results are expressed as ng of secreted insulin per hour. In B and C, 
insulin secretion is presented as percentage of insulin content. Results 
are presented as mean ± SEM of 3 independent wells per condition 
assayed by ELISA. The experiment was replicated 2 times.
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explants were cotransduced with pTRIP ΔU3 loxP.RIP405-SV40 LT and 
pTRIP ΔU3 loxP.RIP405-hTERT lentiviral vectors. They were next trans-
planted under the kidney capsule of SCID mice as previously described 
(10). At 6.5 months later, insulinoma was formed in the transplanted tis-
sue. Three successive rounds of transplantation in SCID mice were used to 
amplify the insulinoma cells prior to establishment of the cell line. Sub-
transplantation and culture conditions are described elsewhere (10)
Immunostaining of pancreatic explants and cell lines. Tissues were fixed in 
3.7% formaldehyde prior to their embedding in paraffin. For immuno-
histochemistry, sections (4-μm thick) were prepared and processed, 
as described previously (10). For immunocytochemistry, EndoC-βH2 
cells were cultured on 12-mm glass cover slips that were coated with 
Matrigel and fibronectin. After 5 days, the cells were then fixed for 
1 hour in 4% paraformaldehyde. The following antibodies were used for 
immunostaining: guinea pig anti-insulin antibody (1/500; A0564, Dako-
Cytomation); rat anti-human C-peptide (1/3,000; AB1921, Beta Cell Biol-
ogy Consortium); mouse anti-glucagon (1/2000; G2654, Sigma-Aldrich) 
or rabbit anti-glucagon (1/1000; 20076-Immuno, Euromedex); rabbit anti-
somatostatin antibody (1/500; A0566, DakoCytomation); mouse anti–
chromogranin A (1/50; M0869, DakoCytomation); rabbit anti-human 
PDX1 antibody (1/2,000) (39) rabbit anti–NKX6-1 antibody (1/500; 
AB1069, Beta Cell Biology Consortium); rabbit anti-SOX9 antibody 
(1/500; AB5535, Millipore); rabbit anti-amylase antibody (1/300; A8273, 
Sigma-Aldrich); mouse anti-SV40 LT (1/50; DP-02, Calbiochem Merck 
Biosciences); mouse anti-human Ki67 antigen (1/50; M7240, DakoCyto-
mation); rabbit anti–carboxypeptidase A antibody (1/500; 1810-0006); rat 
anti-BrdU antibody (1/500; OBT0030, AbD Serotec); and mouse anti-Cre 
recombinase antibody (1/500, CRE-2D8-AS; Euromedex).
The secondary antibodies were fluorescein anti-rabbit antibody (1/200; 
711-096-152, Jackson Immunoresearch Laboratories, Beckman Coulter); 
fluorescein anti-mouse antibody (1/200; IM0819, Immunotech); Alexa 
Fluor 488 goat anti-rat antibody (1/500; A11006, Invitrogen); and Texas 
red anti–guinea pig antibody (1/200; 706-076-148, Jackson Immuno-
research Laboratories).
Digital images of the pancreatic explants and cell lines were captured 
using a cooled 3-chip charge-coupled device camera (Hamamatsu C5810; 
Hamamatsu) that was attached to a fluorescent microscope (Leica; Leitz) 
or with an Olympus Fluoview FV1000 confocal microscope.
Western blot analyses. Protein lysates were subjected to immunoblot-
ting as previously described (40). The following antibodies were used: 
CDK1 (1/1,000; ab18, Abcam), CDK4 (1/1,000; ab6315, Abcam), CCND1 
(1/1,000; RM-9104-S1, NeoMarkers), CCND3 (1/1000; #2936, Cell Sig-
naling), CCNE2 (1/1000; ab40890, Abcam), CCNB2 (1/1,000; ab18250, 
Abcam), and β-actin (1/2,000; A5441, Sigma-Aldrich). Immunoblotting 
experiments were performed at least 3 times.
PCR on genomic DNA. Genomic DNA was extracted from 5 × 105 EndoC-
βH2 and HEK 293T cells (CRL-11268, mycoplasma negative, ATCC) using 
DNeasy Blood & Tissue Kit (QIAGEN). Integrated SV40 LT was PCR ampli-
fied with RIP2 (sense: GTCCAATGAGCACTTTCT) and SV40 LT (anti-
sense: GCAGACACTCTATGCCTGTGTGG) primers generating 892-bp 
PCR products. Integrated hTERT was PCR amplified with hTERT (sense: 
TTCCTACGCTTCATGTGCC) and 3′ LTR (anti-sense: CAGCTGCCTTG-
TAAGTC) primers, generating 1030-bp PCR products respectively.
RNA isolation, reverse transcription, and RT-PCR. Total RNA was isolated from 
all different cell lines using the QIAGEN RNeasy Mini Kit (QIAGEN), as 
described previously (10). First-strand cDNA was prepared using Super-
script reagents (Invitrogen), and RT-QPCR was done using either Assays-on-
Demand kits (Applied Biosystems), LightCycler 480 SYBR Green 1 Master 
Mix (Roche), or LightCycler 1536 DNA Green Master Mix (Roche) and ana-
lyzed on an ABI Prism 7300 Sequence Detector (Applied Biosystems) or on a 
the expression of such cell-cycle–related factors is activated in prolif-
erating EndoC-βH2 cells. CDK1, CCNE2, and CCNB2 should thus 
be used as readouts in screens aiming at defining new signals that 
activate human β cell proliferation. We also observed that, as expect-
ed, CCND3 is expressed both in human islet preparations and in 
EndoC-βH2 cells (30). On the other hand, we observed that CCND1 
is absent from EndoC-βH2 cells (both nonexcised and excised), but 
detectable in islet preparations. Such data suggest that CCND1 is 
not a perfect readout for human β cell proliferation, taking into 
account that CCND1 cannot be detected by immunohistochemistry 
on sections of human adult pancreas (The Human Protein Atlas 
[http://www.proteinatlas.org] and our unpublished data).
In the adult pancreas, human β cell proliferation is extremely 
low (5, 31). It was found that human β cell replication could be 
activated not only upon glucose stimulation (32), but also by 
adenovirus-mediated overexpression of cell-cycle regulators (33). 
It is, however, important to keep in mind that in such studies, 
β cell replication was quantified following BrdU staining that indi-
cates S-phase entry. Recent studies suggest that forced activation 
of cell-cycle entry could give rise to accumulation of DNA damage, 
resulting in a lack of final β cell expansion (9). In this context, it 
is of major importance to measure β cell mass and β cell num-
bers upon stimulation. However, it was recently indicated that 
no laboratory has developed techniques that provide unequivo-
cal evidence of productive human β cell expansion in vitro or in 
vivo (34). The excisable human β cell line we created represents a 
unique tool not only for screening for signals that activate human 
β cell proliferation, but also for determining why human β cells 
proliferate so poorly.
Methods
DNA constructs and lentiviral vector productions. The lentiviral constructs 
pTRIP ΔU3.RIP405-SV40 LT and pTRIP ΔU3.RIP405-hTERT have been 
previously described (10, 35). New lentiviral vectors, pTRIP ΔU3 loxP.
RIP405-SV40 LT and pTRIP ΔU3 loxP.RIP405-hTERT, were constructed. 
The loxP 3′ LTR cassette was amplified by PCR from the SIN-loxP vector 
(provided by B. Thorens, Lausanne University, Lausanne Switzerland) with 
the Kpn primer 5′-CGGGGTACCTTTAAGACCAATGACTTACA-3′ and the 
PacI primer 5′-CGGTTAATTAAGAACTACTACTGCTAGA-3′. The 378-bp 
resulting PCR fragment was digested by KpnI and PacI restriction endo-
nucleases and next inserted in the SV40 LT and hTERT lentiviral vectors to 
replace the ΔU3 3′ LTR by a loxP 3′ LTR. The pTRIP ΔU3 CMV-nlsCre and 
pTRIP ΔU3 CMV-eGFP vectors were described elsewhere (36, 37).
Lentiviral vector stocks were produced by transient transfection of 
HEK 293T cells using p8.9 encapsidation plasmid (ΔVprΔVifΔVpuΔNef), 
pHCMV-G plasmid, which encoded the VSV glycoprotein-G and the pTRIP 
ΔU3 recombinant vector, as previously described (38). The supernatants 
were treated with DNAse I (Roche Diagnostic) prior to their ultracentri-
fugation, and the resultant pellets were resuspended in PBS, aliquotted, 
and then frozen at –80°C until use. The amount of p24 capsid protein was 
quantified by the HIV-1 p24 antigen ELISA (Beckman Coulter). All trans-
ductions were normalized relative to p24 capsid protein quantification.
Human tissues. Human fetal pancreases were extracted from tissue frag-
ments that were obtained immediately after elective termination of preg-
nancy at from 7 to 11 weeks of gestation. Gestational ages were determined 
from the last menstrual period, the crown-rump length as measured by 
ultrasonography, and the hand and foot morphology. Human islets were 
prepared as previously described (10).
Derivation of human β cell line EndoC-βH2. EndoC-βH2 was derived as pre-
viously described with slight modifications. Briefly, human fetal pancreatic 
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nuity Systems), which predicts the qualitative effect of gene expression 
changes in a given data set on biological functions. The predicted activa-
tion state and activation z-score are based on the direction of fold change 
values for those genes in the input data set for which an experimentally 
observed causal relationship has been established.
Access to raw data. All data are MIAME compliant, and the raw data have 
been deposited in a MIAME database (GEO GSE48101).
Statistics. Formalization and statistical analysis for transcriptome studies 
were as follows: a software package (Array Studio, Omicsoft Corp.) was 
used for data normalization and examination of expression levels. Data 
were summarized and normalized using the robust multichip analysis 
(RMA). Two-tailed Limma’s empirical Bayes moderated t test was used for 
the comparison of cell lines. For the comparison of excised versus nonex-
cised human β cell lines, significant differences were defined as a 2-fold or 
greater change in expression passing a multiple hypothesis testing correc-
tion by Benjamini-Hochberg (P ≤ 0.01). For QPCR experiments, statistical 
analysis was performed using 2-tailed Student’s t test.
Study approval. Human fetal tissue was collected in compliance with 
French bioethic legislation. Approval was obtained from the French com-
petent authority, the Agence de Biomedecine (Paris), under approval num-
ber PFS08-005 along with maternal written consent. Experiments using 
animals were reviewed and approved by the Direction Départementale de 
la Protection des Populations (Paris) under agreement number A75-13-19 
in compliance with French legislation.
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1536 LightCycler (Roche) according to the manufacturer’s instructions. The 
list of TaqMan probes and primers is presented in Supplemental Table 2.
Insulin secretion and insulin contents. EndoC-βH2 cells were seeded onto 
Matrigel- and fibronectin-coated 96-well plates at 3.5 × 104 cells/well for 
nonexcised cells and 7 × 104 cells/well for excised cells. Seven days later, 
cells were incubated overnight in culture medium that contained 2.8 mM 
glucose and then in HEPES-buffered Krebs-Ringer buffer (KRB) (115 
mmol/l NaCl, 5 mmol/l KCl, 1 mmol/l CaCl2, 1 mmol/l MgCl2, 24 mmol/l 
NaHCO3, 10 mmol/l HEPES, pH 7.4, and 0.2% BSA) containing 0.5 mM 
glucose for 60 minutes. At the end of this incubation, stimulated insulin 
secretion of the cells was measured by static incubation in KRB that con-
tained varying glucose concentrations for 60 minutes. Glucose stimulation 
was performed in the presence or absence of 500 μM IBMX (Sigma-Aldrich).
For insulin content measurement, cells were lysed directly in the cul-
ture wells with TETG solution for 5 minutes on ice. TETG lysis solution 
contains 20 mM Tris, pH 8.0, 0.1% Triton X-100, 1% glycerol, 137 mM 
NaCl, 2 mM EGTA, and anti-protease tablet (Roche). The lysate was next 
centrifuged at 1,700 g for 5 minutes at 4°C and stored at –20°C until 
insulin ELISA assay.
Insulin secretion and intracellular content of the EndoC-βH2 cells were 
measured in duplicate by ELISA according to the manufacturer’s instruc-
tions using the human insulin kit (Mercodia), which was chosen for the 
absence of crossreactivity with proinsulin.
Transcriptome analysis. 25 ng total RNA each was amplified using the 
Applause 3′-Amp System and subsequently labeled with biotin using the 
Encore Biotin Module following the manufacturer’s instructions (NuGEN 
Technologies). Length distribution of the amplified cDNA products was 
then evaluated using the Agilent 2100 Bioanalyzer (Agilent Technologies).
Hybridizations of the biotin-labeled cDNA to Affymetrix HG-U133 Plus 
2.0 GeneChip microarrays were carried out at ATLAS Biolabs GmbH. A 
total of 3.75 μg cDNA per sample was hybridized to Affymetrix HG-U133 
Plus 2.0 GeneChips (Affymetrix) for 16 to 18 hours at 45°C and 60 rpm 
in a rotating hybridization oven (Hybridization Oven 640; Affymetrix). 
The array was subsequently washed and stained using a fluidics sta-
tion (GeneChip Fluidics Station 450; Affymetrix) following the EukGe_
WSv4_450 fluidics protocol for eukaryotic 3′ expression arrays. Arrays 
were scanned using GeneChip Scanner 3000 7G (Affymetrix). Primary 
data analysis was performed with Affymetrix software GeneChip Operat-
ing System (GCOS), v1.4.
Oligonucleotides-based array (CGH array). CGH array was performed using 
SurePrint G3 Human CGH Bundle (4x180K) (Agilent Technologies) fol-
lowing the manufacturer’s instructions. Briefly, 1 μg of genomic DNA 
corresponding to either a human male control (41) or EndoC-βH2 cells 
at passage 34 or 85 was fragmented by heating at 95°C for 30 minutes. 
Fragmented DNAs were labeled with Cy3 (control DNA) and Cy5 (EndoC-
βH2DNA) fluorescent dUTP, respectively, using the Genomic DNA Enzy-
matic Labeling Kit (Agilent Technologies). Microcon YM 30 spin columns 
(Millipore) were used to remove the unincorporated nucleotides and dyes. 
Hybridizations of labeled DNA to SurePrint G3 Human CGH Bundle 
(4x180K) array (Agilent Technologies) were performed in a hybridization 
oven at 4°C at 20 rpm for 40 hours. Hybridized arrays were then washed 
following the manufacturer’s instructions. Microarray slides were scanned 
on a Nimblegen MS200 Microarray Scanner at a 2-μm resolution. Feature 
extraction was done with Cytogenomics Software (Agilent Technologies). 
Extracted data were imported and analyzed using Nexus 7.0 (Biodiscovery).
Published gene expression profiling data. For comparison of gene expression of 
human β cell lines with human pancreatic islets from organ donors, we also 
utilized published gene expression profiling data (42) (GEO GSE40709).
Downstream effects analysis. Genes found to be significantly differentially 
expressed were used as input for IPAs “downstream effects analysis” (Inge-
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